Samsara BioCapital, 10% Owner of Kalaris Therapeutics KLRS, has filed 12 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $6.2M. The latest trade was on 05/20.

SB

SB

Samsara BioCapital

10% Owner

Company

Kalaris Therapeutics KLRS

First filing

23/02/13

Trades

27 trades

Buys / sales

12 / 0

12-month net buying

$6.2M

Last trade

05/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kalaris TherapeuticsKLRS	Open-market buy	05/20	05/22	244,300 sh	$4.83	$1,179,969	+12.3%
Kalaris TherapeuticsKLRS	Open-market buy	25/12/18	02/17	479,847 sh	$10.42	$5,000,005.74	+32.0%
Mineralys TherapeuticsMLYS	Open-market buy	25/03/13	25/03/17	600,000 sh	$13.50	$8,100,000	+11.8%
NeurogeneNGNE	Open-market buy	24/11/26	24/11/27	48,770 sh4 trades	$25.83avg.	$1,259,622.58	+2.9%
CT Cargo Therapeutics	Open-market buy	24/05/30	24/06/03	294,000 sh	$17.00	$4,998,000	+7.1%
Mineralys TherapeuticsMLYS	Open-market buy	24/02/12	24/02/14	555,555 sh	$13.50	$7,499,992.5	+12.3%
CT Cargo Therapeutics	Open-market buy	23/11/14	23/11/16	666,666 sh	$15.00	$9,999,990	+19.3%
Scholar Rock HoldingSRRK	Open-market buy	23/10/16	23/10/18	2,189,781 sh	$6.85	$14,999,999.85	+47.6%
Mineralys TherapeuticsMLYS	Open-market buy	23/02/14	23/02/16	937,500 sh	$16.00	$15,000,000	+26.2%